Skip to Content
Merck
CN

EHU093491

MISSION® esiRNA

targeting human VASH2 (1)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TGAGGCAGGCTTTGATTCTTCTGAAGGATGCCAAGAATCAAACTAAGGGAGGACTCACTGTTAAAGATGTGTTCTGATGTCTTATATTAAGACCAAATGTGACATGATGTGATTATCTTCCAGTACTTTGCTTTTAGGTACCATTTCATGACATTTTAGGAATGAGTATTGGAAAATATAAAGAATTAGAAAAGCAGCACTTTTTTTTTAATGGAAAAGTCTTCGGTCCAGTGTTACACCTTATAGTGTAATTCAGTCCCTAAGCACAGAATGAATGTCTGGCCTGCATATGGTAGTTACAGTGTAACCTCTGGCTGCAGACCACACAGGACAACCCTAACAGCCTAGTCTTGTATGGTGTAAATATCAAGAGTACAGCTTCAATTTCATTTGCTTTATCTTAGCAACAATGCCAACTCAGGAG

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... VASH2(79805)

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Yasuhiro Suzuki et al.
Cancer science, 108(12), 2342-2351 (2017-09-30)
The vasohibin (VASH) family consists of two genes, VASH1 and VASH2. VASH1 is mainly expressed in vascular endothelial cells and suppresses angiogenesis in an autocrine manner, whereas VASH2 is mainly expressed in cancer cells and exhibits pro-angiogenic activity. Employing adenomatous
Kaori Suenaga et al.
PloS one, 9(9), e104728-e104728 (2014-09-04)
Vasohibin-1 (VASH1) and vasohibin-2 (VASH2), the 2 members of the vasohibin family, have been identified as novel regulators of angiogenesis. VASH1 ceases angiogenesis, whereas VASH2 stimulates sprouting. Here we characterized their functional role in the placenta. Immunohistochemical analysis of human



Global Trade Item Number

SKUGTIN
EHU093491-20UG04061828597888
EHU093491-50UG04061828363124